Dr. Reddy’s launches generic cancer drug Bosutinib in U.S.
A view of Dr. Reddy’s Laboratories in Hyderabad. Dr. Reddy’s Laboratories announced on Saturday (June 13, 2026 ) the first-to-market launch of Bosutinib Tablets 400 mg, a generic equivalent of Pfizer subsidiary Wyeth’s cancer drug Bosulif, in the U.S. Bosutinib Tablets (400mg) was a first-to-file product and thus eligible for 180-days of generic drug exclusivity…
Read More “Dr. Reddy’s launches generic cancer drug Bosutinib in U.S.” »